Hall SD - Search Results

1

Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.

Egbelakin A, Ferguson MJ, MacGill EA, Lehmann AS, Topletz AR, Quinney SK, Li L, McCammack KC, Hall SD, Renbarger JL. Egbelakin A, et al. Among authors: hall sd. Pediatr Blood Cancer. 2011 Mar;56(3):361-7. doi: 10.1002/pbc.22845. Epub 2010 Nov 11. Pediatr Blood Cancer. 2011. PMID: 21225912 Free PMC article.

2

Selective metabolism of vincristine in vitro by CYP3A5.

Dennison JB, Kulanthaivel P, Barbuch RJ, Renbarger JL, Ehlhardt WJ, Hall SD. Dennison JB, et al. Among authors: hall sd. Drug Metab Dispos. 2006 Aug;34(8):1317-27. doi: 10.1124/dmd.106.009902. Epub 2006 May 5. Drug Metab Dispos. 2006. PMID: 16679390

3

Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.

Dennison JB, Jones DR, Renbarger JL, Hall SD. Dennison JB, et al. Among authors: hall sd. J Pharmacol Exp Ther. 2007 May;321(2):553-63. doi: 10.1124/jpet.106.118471. Epub 2007 Feb 1. J Pharmacol Exp Ther. 2007. PMID: 17272675

4

Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients.

Renbarger JL, McCammack KC, Rouse CE, Hall SD. Renbarger JL, et al. Among authors: hall sd. Pediatr Blood Cancer. 2008 Apr;50(4):769-71. doi: 10.1002/pbc.21435. Pediatr Blood Cancer. 2008. PMID: 18085684

5

The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine.

Topletz AR, Dennison JB, Barbuch RJ, Hadden CE, Hall SD, Renbarger JL. Topletz AR, et al. Among authors: hall sd. Drug Metab Dispos. 2013 Sep;41(9):1651-61. doi: 10.1124/dmd.113.051094. Epub 2013 Jun 18. Drug Metab Dispos. 2013. PMID: 23780963 Free PMC article.

6

Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometry.

Dennison JB, Renbarger JL, Walterhouse DO, Jones DR, Hall SD. Dennison JB, et al. Among authors: hall sd. Ther Drug Monit. 2008 Jun;30(3):357-64. doi: 10.1097/FTD.0b013e31816b92c9. Ther Drug Monit. 2008. PMID: 18520608

7

Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin.

Quinney SK, Zhang X, Lucksiri A, Gorski JC, Li L, Hall SD. Quinney SK, et al. Among authors: hall sd. Drug Metab Dispos. 2010 Feb;38(2):241-8. doi: 10.1124/dmd.109.028746. Epub 2009 Nov 2. Drug Metab Dispos. 2010. PMID: 19884323 Free PMC article.

8

CYP2B6 pharmacogenetics-based in vitro-in vivo extrapolation of efavirenz clearance by physiologically based pharmacokinetic modeling.

Xu C, Quinney SK, Guo Y, Hall SD, Li L, Desta Z. Xu C, et al. Among authors: hall sd. Drug Metab Dispos. 2013 Dec;41(12):2004-11. doi: 10.1124/dmd.113.051755. Epub 2013 Jul 11. Drug Metab Dispos. 2013. PMID: 23846872 Free PMC article. Clinical Trial.

9

Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.

Miao J, Jin Y, Marunde RL, Gorski CJ, Kim S, Quinney S, Radovich M, Li L, Hall SD. Miao J, et al. Among authors: hall sd. Pharmacogenomics J. 2009 Oct;9(5):319-26. doi: 10.1038/tpj.2009.21. Epub 2009 Jun 9. Pharmacogenomics J. 2009. PMID: 19506580 Free PMC article.

10

Association between the CYP3A5 genotype and blood pressure.

Ho H, Pinto A, Hall SD, Flockhart DA, Li L, Skaar TC, Cadman P, O'Connor DT, Wagner U, Fineberg NS, Weinberger MH. Ho H, et al. Among authors: hall sd. Hypertension. 2005 Feb;45(2):294-8. doi: 10.1161/01.HYP.0000151361.31736.96. Epub 2004 Dec 13. Hypertension. 2005. PMID: 15596575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page